Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Malin Corporation

Malin Corporation
PUBLIC STATUS
201-300 EMPLOYEES
MLC STOCK SYMBOL
19 INVESTMENTS
$4.07 SHARE PRICE (As of Wednesday Closing)
Description

Malin Corporation PLC is a global life sciences company. Its investee companies are in science and discovery, clinical and commercial sectors. The company's approach is to create shareholder value through selective long-term application of capital and operational expertise to private, pre-trade sale operating businesses in life sciences industry. The company derives all of its revenue from its subsidiary Altan. Altan's revenue is derived from pharmaceutical products.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Commercial Services
Other Industries
Other Capital Markets/Institutions
Stock Exchange
DUB
Primary Office
  • 2 Harbour Square
  • Dun Laoghaire
  • Dublin A96 D6R0
  • Ireland

+353 (01) 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Malin Corporation’s full profile, request a free trial.

Malin Corporation Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.22 - $6.45 $200M $3.97 -$0.50 285K 49M

Malin Corporation Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 247,794 309,688 469,525 489,901
Revenue 39,696 44,843 47,253 46,569
EBITDA (25,095) (50,271) (112,213) (88,270)
Net Income (22,700) (54,637) (111,423) (92,363)
Total Assets 307,444 302,448 369,508 423,731
Total Debt 82,091 83,505 76,181 71,095
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Malin Corporation Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Malin Corporation‘s full profile, request access.

Request full access to PitchBook

Malin Corporation Investments & Acquisitions (19)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 22-Apr-2019 00000 00000 00 00000 Biotechnology
0000000 0000000000 03-Apr-2018 00000 00000 00 000.00 Biotechnology 0. 00000 000000
00000 000000000000 20-Feb-2018 00000 00000 00 0000 Other Devices and Supplies
0000000 0000000000 06-Feb-2017 00000 00000 00 000 Drug Discovery 000000 0000 00.0
Wren Therapeutics 16-Jan-2017 Secondary Transaction - Private Biotechnology 0. 00000 000000
To view this company’s complete investment and acquisition history, request access »

Malin Corporation Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 27-Mar-2015 00000 00000 00 0000 Completed
  • 3 buyers
To view this company’s complete exits history, request access »

Malin Corporation Subsidiaries (2)

Company Name Industry Location Founded
Altan Pharma Drug Discovery Dublin, Ireland 2015
0000000 000000000 Consulting Services (B2B) Sarnen, Switzerland
To view this company’s complete subsidiary history, request access »

Malin Corporation Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Malin Corporation‘s full profile, request access.

Request full access to PitchBook

Malin Corporation Executive Team (7)

Name Title Board
Seat
Contact
Info
Darragh Lyons Chief Executive Officer
Sam Cohen Chief Technology Officer
Andrew von Eschenbach MD Chief Medical Advisor

4 Former Executives

You’re viewing 3 of 7 executives. Get the full list »

Malin Corporation Board Members (9)

Name Representing Role Since Contact
Info
0000 000000 Malin Corporation Lead Independent Non-Executive Director 000 0000

8 Former Board Members

You’re viewing 1 of 9 board members. Get the full list »